Ledger.Open graph →
SEC Form D · filed July 9, 2014

Symbiomix Therapeutics, LLC

Offering
$32.5M
Sold
$19.5M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
NEWARK, NJ
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (8)

Christopher J. Kenny · Chicago, ILExec · DirectorClive J. Harris · Grand Cayman, Cayman IslandsDirectorSusan E. Hodgkinson · New York, NYDirectorDavid Crisalli · Paradise Valley, AZDirectorJ.D. T. Murphy · Bethesda, MDDirectorDaniel T. Thomas · Bethesda, MDExec · DirectorTaylor J. Lauber · New York, NYDirectorMichael S. Weiss · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗